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Thereisaclinicalneedforasyntheticalternativetobonegraftsubstitute(BGS)derivedfromdemineralisedbonematrix.Wereport
the electrospinning of Poly(ε-caprolactone) (PCL) to form a 3-dimensional scaﬀold for use as a synthetic BGS. Additionally, we
have used Poly(vinyl phosphonic acid-co-acrylic acid) (PVPA) to improve bone formation. Fibres were formed using a 10% w/v
PCL/acetone solution. Infrared spectroscopy conﬁrmed that the electrospinning process had no eﬀect on the functional groups
present in the resulting structure. The electrospun scaﬀolds were coated with PVPA (PCL/PVPA), and characterised. The stability
of the PVPA coating after immersion in culture medium was assessed over 21 days. There was rapid release of the coating until day
2, after which the coating became stable. The wettability of the PCL scaﬀolds improved signiﬁcantly, from 123.3 ± 10.8◦ to 43.3
± 1.2◦ after functionalisation with PVPA. The compressive strength of the PCL/PVPA scaﬀolds (72MPa) was signiﬁcantly higher
to that of the PCL scaﬀold (14MPa), and an intermediate between trabecular and cortical bone (7MPa and 170MPa, resp.). The
study has demonstrated that the PCL/PVPA scaﬀold has the desired chemical and biomechanical characteristics required for a
material designed to be used as a BGS.
1.Introduction
There is a need for a synthetic bone graft substitute with
active properties capable of stimulating bone tissue regener-
ation. In the past, research has focused on the development
of bioinert materials [1, 2], materials that have no eﬀect
on the surrounding tissue. More recently, focus has shifted
to bioactive materials, which interact with the surrounding
tissueandencourageboneregenerationandosteointegration
[3]. There are a number of synthetic bone graft substitutes
available; however, none have been found to match or better
the properties associated with autografts and demineralised
bone matrix (DBM). The ideal bone graft substitute must
have certain characteristics and properties in order for
eﬀective bone formation to occur (Table 1).
The morphology of scaﬀolds for bone tissue engineering
has a large inﬂuence on the cell response. Research has
been directed to matching the properties of tissue on the
macroscopic level; however, cells have been found to respond
to the ﬁbrous, nanoscale structure of the extracellular matrix
(ECM) [4]. The natural ECM of bone is composed of
collagen ﬁbres embedded in a matrix of proteoglycans. Bone
cells interact with this matrix, and ideally a scaﬀold that
mimics this morphology of the ECM may aid in optimising
the properties of scaﬀolds to improve bone formation.
Over the last decade, electrospinning has become an
emerging ﬁeld to produce scaﬀolds for bone tissue engi-
neering. Electrospinning is a process by which ﬁbres can
be produced through an electrically charged jet of polymer
solution. A range of materials, from natural polymers to
synthetic polymers have been successfully electrospun into
porous scaﬀolds for use in tissue engineering. The use of
calcium apatites and hydroxyapatite is another approach in
improving bone formation. The ECM of bone, consists of an
inorganic hydroxyapatite phase, therefore the incorporation
of hydroxyapatite into an electrospun, ﬁbrous scaﬀold could
provide biomimicry. Li et al. [5] and Venugopal et al. [6]
are just two research groups of many that have incorporated2 Journal of Tissue Engineering
Table 1: The desirable properties required for a bone tissue
engineered scaﬀold for successful bone regeneration [12–16].
Desirable properties Advantages
Biocompatible (i) Nonimmunogenic
(ii) Nontoxic
Porosity
(i) Ideal porosity ≈ 90%
(ii) Allows the inﬁltration of
cells and nutrients
(iii) Removal of waste
products
(iv) Greater surface area for
cell attachment and
proliferation
Biodegradable
(i) Temporary structure for
the attachment and
proliferation of cells
(ii) Degrades as new bone is
deposited
(iii) Eliminating the need for
further invasive surgery
(iv) Degradation products are
non toxic and easily secreted
through metabolic pathways
Osteoconductive
(i) Support bone growth and
encourage ingrowth of
surrounding bone
Osteoinductive
(i) Induces the diﬀerentiation
of stem cells into mature
osteoblasts
Mechanical properties (i) Stable for surgical handling
(ii) Able to withstand the
forces exerted by the body
hydroxyapatite into a polymeric scaﬀold. Although this ap-
proach has been found to improve matrix formation, there
are problems associated with the dissolution of hydroxyap-
atite and poor healing of more challenging defects or bone
that is associated with low density, such as osteoporosis and
Paget’s disease.
We have identiﬁed a phosphonate-containing poly-
mer, poly(vinyl phosphonic acid-co-acrylic acid) (PVPA)
(Figure 1)[ 7] which is hypothesised to mimic the action
of bisphosphonates, a group of drugs used in the treatment
ofosteoporosis[8].ThecloseproximityofP-Cgroupswithin
the structure are speculated to mimic the P-C-P backbone
found in bisphosphonates which act by inducing osteoclast
apoptosis leading to an increase in bone formation [9–
11]. The close proximity of the P-C groups coupled with
the strong negative charge of the ions, the PVPA polymer
is hypothesised to chelate calcium ions (Figure 2). Phos-
phonic acid containing polymers have also been described
to improve mineralisation in a dose-dependent manner,
therefore promoting osteoblast maturation.
Recently, researchers have attempted to incorporate bis-
phosphonates within substrates such as hydroxyapatite and
demonstratedosteoclastapoptosis;however,thesecomposite
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Figure 1: The chemical structure of poly(vinyl phosphonic acid-
co-acrylic acid). The close proximity of the P-C groups with other
molecules mimics the P-C–P backbone found in bisphosphonates.
P
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Figure 2: The PO3H2 group present in PVPA is hypothesised to
chelate Ca2+ ions by forming a “bone hook,” which will lead to an
increase in mineralisation.
systems fail to provide the mechanical support required in
load-bearingapplications[17,18].Themodiﬁcationofpoly-
mer substrates with bisphosphonates has been investigated,
and although the mechanical strength of the scaﬀold may
improve, the well-documented side eﬀects of bisphospho-
nates may still occur [19]. A polymeric substitute could oﬀer
a solution to these problems.
In this study electrospinning has been used to fabricate
as c a ﬀold composed of Poly(ε-caprolactone) and Poly(vinyl
phosphonic acid-co-acrylic acid) (hereafter referred to as
PCL/PVPA) for use as a synthetic bone graft substitute. The
ﬁbrous nature of the scaﬀold resembles the collagen ﬁbres
found in the extracellular matrix of bone thus providing a
biomimetic structure for cell attachment and proliferation.
The combined positive eﬀects of the PVPA polymer on the
osteoblast andosteoclast cellarehypothesised toleadtoanet
increase in bone formation. The aim of the present study is
to describe the fabrication process and evaluate the physical
and biomechanical properties of the novel polymer system
andtodescribethepreliminaryresultsobtainedfrominvitro
cell culture using osteoblast and osteoclast cells.
2.MaterialsandMethods
2.1. Fabrication of PCL Fibres
2.1.1. Electrospinning. A 10%w/v polymer solution of PCL
(Mn ≈ 80,000) in acetone was electrospun using an applied
voltage 20kV, ﬂow rate 0.05mL/min, and a needle collectorJournal of Tissue Engineering 3
distance15cm.Fibreswerecollectedonagroundedcollector
plate to give a randomly orientated morphology.
2.1.2. Preparation of PCL/PVPA Films. Films of PCL/PVPA
were prepared by immersing the electrospun PCL mat in a
reservoir of 15% PVPA in deionised water for 24 hours. The
ﬁlms were removed from the PVPA and formed into a 3D
spherical scaﬀold. The scaﬀo l d sw e r ea i rd r i e df o r4 8h o u r s
and then heat-treated at 55◦C for 24 hours.
2.2. Characterisation of Polymer Scaﬀolds
2.2.1. Morphology of Scaﬀolds. Scaﬀolds were mounted onto
aluminium stubs using carbon tabs (Agar Scientiﬁc, UK)
and then carbon coated using the Edwards E306A Coating
System. The coated scaﬀolds were viewed in a Phillips XL30
Field Emission Gun Scanning Electron microscope (FEG-
SEM, Phillips XL30) using an accelerating voltage of 5kV, a
spot size of 3, and a working distance of 10mm. The average
ﬁbre diameter was calculated by measuring the diameter
of 100 ﬁbres using Image J software (National Institutes of
Health, USA).
2.2.2. Phosphorous Concentration. The concentration of
phosphorous within the scaﬀolds was monitored using
energy dispersive X-ray spectroscopy (EDX) after drying
the scaﬀolds upon immersion in Dulbecco’s Modiﬁed Eagle
Medium (DMEM) for a total of 21 days. At days 2, 7, 14, and
21, scaﬀolds were removed from the DMEM, washed with
deionised water, and air dried for 24 hours.
Scaﬀolds were mounted and carbon coated using the
Edwards E306A Coating System. The coated scaﬀolds were
viewed in a Phillips XL30 Field Emission Gun Scanning
Electron microscope (FEG-SEM, Phillips XL30) using an
acceleratingvoltageof5kVandaworkingdistanceof10mm.
The FEG-SEM has an EDX spectrometer, which detects the
released X-rays from the scaﬀold. EDX analysis was carried
on PCL/PVPA scaﬀolds that had undergone heat treatment
a n du n h e a t e ds c a ﬀolds in triplicate.
2.2.3. Wettability of Scaﬀolds. The contact angle of the
scaﬀolds was tested using the Kr¨ υss DSA 100 Drop Size Anal-
yser. The wettability of electrospun PCL, and electrospun
PCL/PVPA was tested on three randomly selected scaﬀolds.
A1 0 μL droplet of distilled water was released onto each
scaﬀold using an 8-gauge needle (BD Plastics, UK), the
change in contact angle was measured over 7.20 seconds.
2.2.4. Determination of Functional Groups. Fourier Trans-
form Infrared Spectroscopy (FTIR) spectra were collected
using the Thermo Nicolet Nexus FTIR (Cambridge, UK).
Scaﬀoldsweremounted on to thesmart orbit sampler, which
was connected to the FTIR Nexus. OMNIC software was
used for the analysis of the collected spectra. Spectra’s were
obtained by accumulating 32 scans in the range of 400–
4000cm−1 w i t har e s o l u t i o no f4c m −1. The data is expressed
as the average of 3 spectra for each scaﬀold.
2.2.5. Thermal Properties of Polymer Scaﬀolds. Diﬀerential
scanning calorimetry (DSC, Q100 V9.8) was used to deter-
mine the thermal properties of the various polymer ﬁlms.
Scaﬀolds were sealed hermetically in aluminium pans and
heated within the range of −90◦C to 150◦C with a heating
rate of 10◦C/min. The nitrogen gas ﬂow rate was 50mL/min
and measurements were carried out at a scanning rate of
10◦C/min using a heat/cool/heat cycle. The repeated heating
andcoolingremovesanythermalhistory.Anemptyreference
pan was used to subtract the blank so that only the thermal
properties of the material were detected.
2.2.6. Mechanical Properties of Polymer Scaﬀolds. The com-
pressive strength and Young’s modulus of the scaﬀolds were
determined using the Instron 1122 mechanical tester at a
temperature of 23 ± 1◦C and relative humidity of 50 ± 2%.
A compression plate attachment was used for the test. A
crosshead speed of 50mm/min was used and the distance
between the two plates was 11mm. The full-scale load was
set at 0.20kN.
2.3. Assessment of Biocompatibility
2.3.1. Osteoblast Culture. Human osteoblast cells (HOBs)
(The European Collection of Cell Cultures, UK; cell line
no. 406-05a) were cultured in Dulbecco’s modiﬁed Eagles
medium (DMEM; Gibco, Paisley) supplemented with 10%
FBS, antibiotics (100U/mL penicillin, 100mg/mL strep-
tomycin) and 50μM ascorbic acid. Culture medium was
replenished every 2 days. Scaﬀolds were immobilised in 24-
well plates using Cell Crown inserts (Scaﬀdex, Finland) and
sterilised using a series of increasing ethanol concentrations.
Cells were counted and seeded onto scaﬀolds at a density
of 40,000cells/cm2. Plates were cultured under standard
conditions, at 37◦C with 95% humidity and 5% CO2.
Atday14,cellswereﬁxedwith3%paraformaldehydeand
stained using Alexa Fluor 488 phalloidin and DAPI Prolong
(Invitrogen, UK).
2.3.2. Osteoclast Culture. Human osteoclast precursor cells
(Lonza, UK) were dispersed in osteoclast precursor basal
medium (α-MEM) supplemented with 10% FBS, 66ng/mL
RANK-L, 33ng/mL M-CSF, antibiotics (100U/mL peni-
cillin, 100μg/mL streptomycin), and 2mM L-glutamine
(all supplied by Lonza, UK). Scaﬀolds were sterilised and
preparedasdescribedinSection 2.3.1Cellswerecountedand
seeded onto scaﬀolds and glass cover slips (Agar Scientiﬁc,
UK) at a density of 60,000cells/cm2. Plates were cultured
under standard conditions, at 37◦C with 95% humidity and
5% CO2.
At days 1 and 7, cells were washed with PBS and ﬁxed
in 1.5% glutaraldehyde in PBS for 30 minutes at 4◦C.
The scaﬀolds were then dehydrated through a series of
increasing concentrations of ethanol. Samples were dried
using hexamethyldisilazane (HMDS). Samples were carbon
coated using the Edwards E306A Coating System and viewed4 Journal of Tissue Engineering
(a) (b)
Figure 3: (a) Photograph of PCL/PVPA 3D scaﬀold, scale bar 1cm (b) SEM micrograph of PCL ﬁbres treated with PVPA, ﬁbres had an
average diameter of 269 ± 102nm. Scale bar 5μm.
in a Phillips XL30 Field Emission Gun Scanning Electron
microscope (FEG-SEM, Phillips XL30) using an accelerating
voltage of 5kV and a spot size of 3.
2.4. Statistical Analysis. Statistical evaluation of data was
performed using GraphPad software package. Data are
reported as mean ± standard deviation (SD) at a signiﬁcance
level of P<0.05. One-way ANOVA with the Bonferroni test
was carried out to compare the groups.
3. Results andDiscussion
The design of a synthetic bone graft substitute for load-
bearing applications requires consideration of the chemical,
biomechanical, and biological properties. Here we describe
the fabrication, and characterisation of a 3D electrospun
scaﬀold and its potential use as a bone graft substitute.
3.1. Materials Characterisation. Electrospun ﬁbres closely
mimic the extracellular matrix of bone [21–23], the ﬁbres
obtained during this study had an average diameter of 269 ±
102nmwithmostﬁbresdistributedbetween100and300nm
(Figure 3).
The stability of the PVPA coating was examined using
EDX analysis (Figure 4). The presence of phosphorous was
monitored over a 21-day period after immersion of the
scaﬀolds in DMEM. Scaﬀolds that had not undergone heat
treatmentweretestedasacontrol.Therewasasharpdecrease
in phosphorous wt% from day 0 to day 2 on both scaﬀold
types, decreasing from 3.3 ± 0.08wt% to 1.24 ± 0.13wt% on
heat-treated scaﬀolds and to 0.12 ± 0.02wt% on untreated
scaﬀolds. The initial release of phosphorous in the ﬁrst
two days of immersion could be advantageous in vivo as
the apoptosis of osteoclasts immediately after implantation
would allow osteoblasts to secrete matrix.
After day 2, there was no signiﬁcant change in phos-
phorous concentration over the remaining culture period as
shown in Figure 5; however, there was a signiﬁcant diﬀerence
in concentration between the two scaﬀold types; scaﬀolds
which had undergone a heat treatment had a signiﬁcantly
higher (P<0.001) concentration of phosphorous compared
to untreated scaﬀolds. This result suggests that after the
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Figure 4: The phosphorous concentration on the surface of the
polymeric scaﬀo l d se x a m i n e dt h r o u g hE D Xo v e r2 1d a y s( n = 4).
initial dissolution of PVPA, the coating becomes stable upon
heat treatment.
It is hypothesised that PVPA is bound to PCL at the
interface as a monomolecular layer, and there are subsequent
interactions between the unbound PVPA molecules. It is
suggested that up till day 2, the unbound PVPA are gradually
released. This is followed by stabilisation of the coating as all
unboundPVPAarereleasedandonlythemonolayerofPVPA
exists on the surface.
EDX revealed that the heat treatment of PCL/PVPA
prevents the PVPA from being removed from the scaﬀold.
Duringheattreatmentthescaﬀoldistakenaboveitscrystalli-
sation temperature. This leads to movement of the polymer
chains and cooling leads to subsequent crystallisation of
the polymer chains. The PVPA could become “trapped”
during the heating and cooling of the polymer chains, which
subsequently provides a stable PCL/PVPA scaﬀold.
The wettability of PCL/PVPA and PCL scaﬀolds was
determined through water contact angle testing (Figure 5).
There is a signiﬁcant diﬀerence in the contact angle of
PCL scaﬀolds once treated with PVPA, the contact angle isJournal of Tissue Engineering 5
(a) (b)
Figure 5: Photograph images of 10μL water droplet on (a) PCL scaﬀold, (b) PCL/PVPA scaﬀold (n = 3).
Table 2: Water contact angle of PCL and PCL/PVPA scaﬀolds (n =
3).
Material Contact angle
Electrospun PCL 123.3 ± 10.8◦
PCL/PVPA 43.3 ± 1.2◦
reduced from 123.3 ± 10.8◦ to 43.3 ± 1.0◦ (Table 2). The
use of PCL without any pretreatment can be limited due
to the hydrophobic nature of the polymer. The wettability
testing demonstrates that the treatment of PCL with PVPA
signiﬁcantly improves the wetting nature of the polymer and
no further treatment would be needed before cell seeding.
PVPA consists of negatively charged –COOH and –OH
functional groups. The oxygen atoms exert a greater “pull”
on the hydrogen atoms and consequently one of the atoms
become electronegative. These groups are said to be polar
and are therefore attracted to water as water is also polar,
this property will make PVPA hydrophilic and consequently
when PCL is treated with PVPA, the surface becomes
hydrophilic.
FTIR analysis was employed to identify any changes in
the chemical structure that could have occurred during the
electrospinning process. When we compare electrospun PCL
and a PCL pellet, the spectra reveals that there is no diﬀer-
ence in the functional groups present after-electrospinning
(Figure 6(a)).Thechangein thespectraupon theaddition of
PVPAtoPCLrevealsa–OHpeakat3450cm−1 (Figure 6(b)).
This peak can be owed to the PVPA polymer, which contains
many –OH functional groups. The C–H peaks present at
1750cm−1 and 2850cm−1 in electrospun PCL remained
unchanged in the presence of PVPA. FTIR analysis has
demonstrated that the electrospinning process has no eﬀect
on the functional groups present in the resulting structure.
The thermal properties of the polymer scaﬀolds were
determined through DSC; the results are outlined in Table 3.
The treatment of PCL with PVPA has had no signiﬁcant
diﬀerence on the thermal properties of the scaﬀolds. This is
most likely due to there being only a low concentration of
Table 3: The melting temperature, crystallisation temperature and
glass transition temperature of PCL and PCL/PVPA scaﬀolds (n =
3).
Material
Melting
temperature
(Tm)( ◦C)
Crystallisation
temperature
(Tc)( ◦C)
Glass transition
temperature
(Tg)( ◦C)
PCL scaﬀold 56.53 ± 1.42 26.94 ± 1.76 −59.22 ± 2.79
PCL/PVPA
scaﬀold 56.79 ± 2.75 27.74 ± 1.23 −59.88 ± 1.68
Table 4:BiomechanicalpropertiesassociatedwithPCL,PCL/PVPA
scaﬀolds, cortical bone, and trabecular bone∗ [20].
Material Compressive
strength (MPa)
Young’s modulus
(GPa)
PCL scaﬀold 14 ± 1.2 0.9 ± 0.1
PCL/PVPA
scaﬀold 72 ± 4.9 3.9 ± 0.9
Cortical bone∗ 170–193 14–20
Trabecular bone∗ 7–10 0.05–0.5
PVPA in comparison to the PCL substrate therefore having
no signiﬁcant eﬀect on the thermal properties.
T h em e c h a n i c a lp r o p e r t i e so fam a t e r i a lt ob eu s e di n
bone tissue engineering have an important role in the
scaﬀold design. Mechanical testing was carried out to deter-
mine the compressive strength and Young’s modulus of the
polymerscaﬀolds.Thetwopropertiesweredeterminedusing
previously reported equations and the load-displacement
curve obtained (Figure 7). The load-displacement curve dis-
plays a signiﬁcant diﬀerence between the load withstood by
PCLandPCL/PVPA.ThecompressivestrengthofPCL/PVPA
scaﬀolds has been calculated to be 72MPa, this is signiﬁ-
cantly higher than that of PCL scaﬀolds (14MPa) (Table 4).
A similar trend was determined for the Young’s modulus,
the Young’s modulus of PCL/PVPA was determined to be
3.9GPa and 0.9GPa for PCL scaﬀolds. The compressive
strength of PCL/PVPA is ten-times greater than that of6 Journal of Tissue Engineering
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Figure 6: (a) FTIR spectra for a PCL pellet and electrospun PCL. (b) FTIR spectra for PVPA, PCL/PVPA, and electrospun PCL.
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Figure 7: A load-displacement curve showing the loading pattern
up to 50% compression of PCL and PCL/PVPA scaﬀolds (n = 5).
trabecular bone (7–10MPa), and the Young’s modulus is
eight times greater (0.05–0.5GPa).
The signiﬁcant increase in mechanical strength in the
presence of PVPA could be owed to the presence of
intermolecular interactions between the PVPA-coated PCL
scaﬀolds.Thehighlynegativelychargedoxygenatomswithin
PVPA are attracted to hydrogen atoms present within the
scaﬀolds structure, this interaction provides strength to the
resulting structure and hence an increase in the compressive
strength.
In the area of bone tissue engineering it is important to
closely mimic the natural strength of bone as possible. This
can be problematic due to the high compressive strength
of bone. The mismatch of mechanical properties between
natural bone and synthetic materials can lead to failure of an
implanted material. The mechanical properties suggest that
the scaﬀolds have suﬃcient mechanical strength to be used
as a packing substance in trabecular bone voids. The increase
in the mechanical properties of PCL/PVPA scaﬀolds is owed
to the properties of PVPA. The solidiﬁcation of PVPA gives
rise to a strong material that is hypothesised to be stronger
than PCL. The tensile and compressive properties of PVPA
have not been tested. It is hypothesised that the presence of
PVPA throughout the PCL structure would provide strength
throughout the structure and hence suﬃcient mechanical
support in bone tissue. The mechanical properties of the
scaﬀold can be tailored by changing the amount of PVPA
presentwithinthestructure.Anoptimum concentrationwill
h a v et ob ed e t e r m i n e dt oa l l o wf o ra na d v a n t a g e o u se ﬀect on
c e l l sg r o w t ha sw e l la so nt h em e c h a n i c a lp r o p e r t i e s .
3.2. Biocompatibility. Preliminary studies have shown that
osteoblast cells are able to favourably attach and proliferate
on the PCL/PVPA scaﬀold (Figure 8). After 14 days in
culture, a more pronounced cytoskeleton was observed in
osteoblasts cultured on PCL/PVPA scaﬀolds, this is most
likely to be due to superior spreading of the cells due to
the signiﬁcantly lower water contact angle of the PCL/PVPA
scaﬀold when compared to PCL scaﬀolds [23, 24]. Further
studies investigating the eﬀects of the scaﬀo l do no s t e o b l a s t
activity will be carried out.
Scanning electron microscopy (SEM) was used to visu-
alise osteoclasts cultured on PCL, PCL/PVPA, and glass
substrates over 7 days under standard conditions. At day 1,
there were viable cells present on all scaﬀold types (Figure 9).
A high number of cell colonies formed on PCL/PVPA
scaﬀolds. It is not clear whether this is due to the hydrophilic
natureofthesubstratewhichencouragesrapidattachmentof
cells or whether it is due to the PVPA polymer causing cells
to group together and a possible indicator of the initiation
of apoptosis. Cells present on both PCL and PCL/PVPAJournal of Tissue Engineering 7
(a) (b) (c)
Figure 8: Fluorescence micrograph images of human osteoblast cells cultured for 14 days on (a) PCL/PVPA, (b) PCL, and (c) Tissue culture
plastic. Staining of nuclei (DAPI, blue) and cytoskeleton (Alexa Fluor 488 phalloidin, green). Scale bar 25μm.
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Figure 9: Scanning electron microscope images of osteoclast precursor cells cultured on PCL, PCL/PVPA and glass substrates at day 1 and
day 7. PCL and PCL/PVPA, scale bar 5μm, glass, scale bar 10μm.
scaﬀolds displayed superior spreading when compared to the
glass substrate. This can be owed to the morphology of the
electrospun ﬁbres; the ﬁbrous structure provides a greater
surface area for cell attachment, proliferation and integrin
binding. At day 7, there was a marked diﬀerence in the
morphology of cells present on the substrate types. Large,
multinucleated cells formed on PCL substrates, which had
anelongated,roundedmorphology.Therewereveryfewcells
present on PCL/PVPA substrates; there was evidence of cell
debris on the surface. In contrast to cells present on PCL8 Journal of Tissue Engineering
substrates, cells on the glass surface were multinucleated,
however, with a ﬂattened morphology.
It is hypothesised that the presence of PVPA in culture
leads to the formation of nonhydrolysable analogues of ATP,
AppCp. The accumulation of these analogues within the
osteoclast cells leads to loss of its function and eventual
cell death [25, 26]. From SEM analysis, it has been shown
that cells are present at day 1, suggesting that cells are not
apoptosing immediately upon treatment with PVPA.
4. Conclusions
Poly(ε-caprolactone)/poly(vinyl phosphonic acid-co-acrylic
acid) (PCL/PVPA) scaﬀolds have been fabricated using the
electrospinning process for use as an active material to
enhance bone tissue formation. The concentration of PVPA
on the PCL substrate was monitored over 21 days; initially
there was a rapid release of PVPA from the PCL substrate,
followed by stabilisation of the polymer monolayer. This
eﬀect could be advantageous in vivo as there would be
initialapoptosisofosteoclastcells,providingagreatersurface
area for osteoblast attachment, proliferation, and subsequent
matrix deposition. The attachment of osteoblast cells will
be further enhanced due to the hydrophilic nature of the
PCL/PVPA scaﬀold.
The compressive strength of PCL/PVPA has been deter-
mined to be an intermediate between cortical bone and
trabecular bone, and signiﬁcantly higher than PCL alone.
The strength can be altered depending on the concentration
of PVPA. Here we have reported that osteoblast cells are able
to attach and proliferate on the PCL/PVPA surface whereas
a decrease in osteoclast number is observed. Further studies
will be carried out to determine the optimum concentration
of PVPA which elicits advantageous materials properties as
well as providing the desired biological eﬀects. This study
has demonstrated that the PCL/PVPA scaﬀold has some of
the materials properties that are desired in the design of
materials for bone tissue engineering.
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